Yarden Y - Search Results

1

An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.

Ben-Levy R, Peles E, Goldman-Michael R, Yarden Y. Ben-Levy R, et al. Among authors: yarden y. J Biol Chem. 1992 Aug 25;267(24):17304-13. J Biol Chem. 1992. PMID: 1355090 Free article.

2

A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

Yayon A, Zimmer Y, Shen GH, Avivi A, Yarden Y, Givol D. Yayon A, et al. Among authors: yarden y. EMBO J. 1992 May;11(5):1885-90. doi: 10.1002/j.1460-2075.1992.tb05240.x. EMBO J. 1992. PMID: 1316275 Free PMC article.

3

Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.

Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y. Peles E, et al. Among authors: yarden y. Cell. 1992 Apr 3;69(1):205-16. doi: 10.1016/0092-8674(92)90131-u. Cell. 1992. PMID: 1348215

4

Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation.

Peles E, Lamprecht R, Ben-Levy R, Tzahar E, Yarden Y. Peles E, et al. Among authors: yarden y. J Biol Chem. 1992 Jun 15;267(17):12266-74. J Biol Chem. 1992. PMID: 1351056 Free article.

5

Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.

Stancovski I, Peles E, Ben Levy R, Lemprecht R, Kelman Z, Goldman-Michael R, Hurwitz E, Bacus S, Sela M, Yarden Y. Stancovski I, et al. Among authors: yarden y. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):95-103. doi: 10.1016/0960-0760(92)90192-l. J Steroid Biochem Mol Biol. 1992. PMID: 1356018 Review.

6

Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.

Lev S, Givol D, Yarden Y. Lev S, et al. Among authors: yarden y. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):678-82. doi: 10.1073/pnas.89.2.678. Proc Natl Acad Sci U S A. 1992. PMID: 1370584 Free PMC article.

7

A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses.

Lev S, Yarden Y, Givol D. Lev S, et al. Among authors: yarden y. J Biol Chem. 1992 May 25;267(15):10866-73. J Biol Chem. 1992. PMID: 1375232 Free article.

8

Dimerization and activation of the kit receptor by monovalent and bivalent binding of the stem cell factor.

Lev S, Yarden Y, Givol D. Lev S, et al. Among authors: yarden y. J Biol Chem. 1992 Aug 5;267(22):15970-7. J Biol Chem. 1992. PMID: 1379243 Free article.

9

Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers.

Hadari YR, Tzahar E, Nadiv O, Rothenberg P, Roberts CT Jr, LeRoith D, Yarden Y, Zick Y. Hadari YR, et al. Among authors: yarden y. J Biol Chem. 1992 Sep 5;267(25):17483-6. J Biol Chem. 1992. PMID: 1381348 Free article.

10

Flg-2, a new member of the family of fibroblast growth factor receptors.

Avivi A, Zimmer Y, Yayon A, Yarden Y, Givol D. Avivi A, et al. Among authors: yarden y. Oncogene. 1991 Jun;6(6):1089-92. Oncogene. 1991. PMID: 1648703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters